Union Korea Pharm Co Ltd banner
U

Union Korea Pharm Co Ltd
KOSDAQ:080720

Watchlist Manager
Union Korea Pharm Co Ltd
KOSDAQ:080720
Watchlist
Price: 2 725 KRW -10.21% Market Closed
Market Cap: ₩21.6B

Wall St Price Targets

Price Targets Summary
Union Korea Pharm Co Ltd

There are no price targets for Union Korea Pharm Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Union Korea Pharm Co Ltd Competitors:
Price Targets

Revenue
Forecast

-4% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-4% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 7 years is 9%.

Gross Profit
Forecast

-14% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-14% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been -14%. The projected CAGR for the next 7 years is 23%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Union Korea Pharm Co Ltd's stock price target?
Not Available

Union Korea Pharm Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Union Korea Pharm Co Ltd?
Projected CAGR
9%

Over the last 8 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 7 years is 9%.

What is the Gross Profit forecast for Union Korea Pharm Co Ltd?
Projected CAGR
23%

Over the last 8 years, the compound annual growth rate for Gross Profit has been -14%. The projected CAGR for the next 7 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett